Carla Caccia
Zambon (Italy)(IT)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neuroscience and Neuropharmacology Research, Chemical synthesis and alkaloids, Neurotransmitter Receptor Influence on Behavior, Cyclopropane Reaction Mechanisms
Most-Cited Works
- → Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs(2007)587 cited
- → Safinamide(2006)190 cited
- → Determinants and Consequences of Adherence to the Dietary Approaches to Stop Hypertension Diet in African-American and White Adults with High Blood Pressure: Results from the ENCORE Trial(2012)161 cited
- → Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor(2009)106 cited
- → D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions(1986)105 cited
- → Biochemical and Electrophysiological Studies on the Mechanism of Action of PNU-151774E, A Novel Antiepileptic Compound(1999)89 cited
- → The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature(2021)63 cited
- → Solid-Phase Synthesis and Insights into Structure−Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase(2007)55 cited
- → Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia(2017)50 cited
- → Pressor Response to Intravenous Tyramine in Healthy Subjects After Safinamide, a Novel Neuroprotectant With Selective, Reversible Monoamine Oxidase B Inhibition(2003)43 cited